Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific
Hemogenyx Pharmaceuticals Announces Manufacturing Partnership with Made Scientific to Advance HG-CT-1 CAR-T Therapy CITY OF LONDON, GB / ACCESS Newswire...
Hemogenyx Pharmaceuticals Announces Manufacturing Partnership with Made Scientific to Advance HG-CT-1 CAR-T Therapy CITY OF LONDON, GB / ACCESS Newswire...
Study reveals how Cytovale's IntelliSep® sepsis test enables early sepsis risk stratification and more precise documentation, increasing SEP-1 compliance by...
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...
Chemotherapy-free combination regimen has the potential to usher in new era for first-line treatment, with median overall survival projected to...
- 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5...
No-cost access available to qualified researchers via open-source federated data platformSAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research...
Medicaid payment suspensions disrupt operations for Housing Stabilization providers and vulnerable clients in Minnesota. MINNEAPOLIS, MN / ACCESS Newswire /...
DELRAY BEACH, Fla., Sept. 6, 2025 /PRNewswire/ -- The global Digital Health Market, valued at US$162.1 billion in 2024, stood...
DELRAY BEACH, Fla., Sept. 6, 2025 /PRNewswire/ -- The global sensor patch market is projected to grow from USD 6.32...
Black Book Research pre-event survey reveals attendee priorities: smart hospitals, population health, and compliance-ready solutions DUBAI, UAE / ACCESS Newswire...
After decades of outreach and evidence—never refuted—it is urgent to fund two 3D-CBS devices that could halve cancer deaths, and...
New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with EGFR TKIs1 BEERSE, BELGIUM ,...
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a...
Mobile, Alabama , Sept. 05, 2025 (GLOBE NEWSWIRE) -- Helios Alliance, a nonprofit dedicated to improving public health outcomes, announced...
Challenge is second of three in a multiyear partnership to help shape the future of longevity innovation C$ unless otherwise...
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- NYU Langone Health's Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders...
Media are encouraged to join a webinar hosted by the ISS National Lab and NASA on Sept. 10 featuring science...
AURORA, CO / ACCESS Newswire / September 5, 2025 / The Global PAD Association has presented the 2025 Walking As...
Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...
A QI evaluation of a Butterfly-enabled POCUS program—centered on lung ultrasound for pulmonary congestion and assisted by an AI B-line...